BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 3 filers reported holding BIONTECH SE in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,608 | -17.2% | 116,071 | -17.8% | 0.05% | -15.9% |
| Q2 2023 | $15,234 | +10.1% | 141,166 | +27.0% | 0.06% | +3.3% |
| Q1 2023 | $13,842 | -70.5% | 111,127 | -64.4% | 0.06% | -73.6% |
| Q4 2022 | $46,914 | -99.6% | 312,164 | +228.3% | 0.23% | +230.0% |
| Q3 2022 | $12,838,000 | +30.4% | 95,072 | +44.0% | 0.07% | +40.0% |
| Q2 2022 | $9,843,000 | +35053.6% | 66,018 | +39910.9% | 0.05% | – |
| Q1 2022 | $28,000 | -97.6% | 165 | -96.5% | 0.00% | -100.0% |
| Q4 2021 | $1,150,000 | -98.4% | 4,666 | -98.2% | 0.00% | -98.5% |
| Q3 2021 | $71,025,000 | -52.6% | 259,375 | -61.2% | 0.27% | -51.9% |
| Q2 2021 | $149,690,000 | – | 667,832 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |